# Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

> **NCT00611754** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 15 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Oxaliplatin, 5-FU

## Key facts

- **NCT ID:** NCT00611754
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2003-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2008-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611754, "Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00611754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*